Wanbury
WANBURYNSE

Wanbury

₹300.452.60 (0.87%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
295.10
Today’s high
311.90
52 week low
161.50
52 week high
315.20
Open price
300.00
Previous close
297.85
Live volume
4,96,194
Lower circuit
240.40
Upper circuit
360.50

Fundamentals

Market Cap
₹1,051Cr
ROE
51.51%
P/E Ratio(TTM)
24.45
EPS(TTM)
12.30
P/B Ratio
13.57
Dividend Yield
0.00%
Industry P/E
36.18
Book Value
22.16
Debt to Equity
2.98
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
MAR '26
Revenue (Cr)
₹165
+1.33%
Profit (Cr)
₹21.70
+37.69%
050100150200
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue growthValue
1Y (TTM)-5%
3Y CAGR+6%
Profit growthValue
1Y (TTM)+7.0%
3Y CAGR-28%

About

Wanbury Limited is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and Formulations. It is one of the world's largest producers of Metformin (anti-diabetic). The company successfully completed its first commercial shipment of high-potency anaesthetic APIs to the European market from its state-of-the-art Tanaku facility.;
CEO/MD
Mr. Mohan Kumar Rayana
Founded in
1988
NSE symbol
WANBURY

Shareholding Pattern

Mar '26
Dec '25
Sep '25
Jun '25
Mar '25
Retail And Others
58.40%
Promoters
39.76%
Foreign Institutions
1.84%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹897.65
+7.80 (0.88%)
L
    H
    22,239.7737.384.37
    PfizerPFIZER
    ₹4,736.30
    +4.90 (0.10%)
    L
      H
      21,690.3730.025.16
      ₹8,291.00
      +173.50 (2.14%)
      L
        H
        20,678.38110.2723.69
        ₹1,449.90
        +18.70 (1.31%)
        L
          H
          20,101.5131.045.15
          Livesquawk
          Wanbury's promoter group's 40.65% equity pledge has been released. Borrowing costs for Wanbury to fall below 10% annually from July 1, 2026.
          Livesquawk
          Wanbury Limited completes TGA inspection in Tanuku, Andhra Pradesh. Receives GMP certificate, enabling shipment of 3 additional APIs.
          2026
          29
          May
          Quarterly & Annual Result
          Release date
          14
          May
          Quarterly & Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks